Introduction

Celiac sprue is a frequently unrecognized diagnosis in the adult population. Although this disease is referred to by other descriptions such as adult celiac disease, nontropical sprue, and gluten-sensitive enteropathy; several key features must be present. Classically, these include evidence of malabsorption, pathological damage of the small intestine, and response to a gluten-free diet.17 Although the first descriptions of celiac sprue date back to the first or second century, A.D., detailed clinical aspects of the disease were not described until the late 1800’s and early 1900’s. This included work by Gee on children and Thompson on adults.2 Then in the 1940’s, Dr. W.K. Dicke, a Dutch pediatrician, noted that dietary grains were the causative factor. He observed during World War II that the symptoms of his celiac sprue patients improved during the time that food (grain) was scarce. After the war, when food was more plentiful, their symptoms returned.14 It wasn’t until the 1950’s that biopsies were discovered to be helpful in diagnosing the disease. At approximately the same time the peroral suction biopsy was perfected, thus allowing biopsies to be safely conducted on the general population. Now the prevalence of celiac sprue in the United States is thought to be 1 in every 3,000 - 10,000 adults. This is believed to be a gross underestimation as many are asymptomatic or only have vague symptoms. The disorder is more common in the Western European population with as many as 1 in 300 adults being affected in Western Ireland. The disease is rare in those of Oriental or African ancestry.19

 

Etiology and Pathogenesis

The pathogenesis of celiac sprue has still not been clearly defined. The debate currently focuses on environmental factors, genetics, and immunology all having an influence. One hypothesis that has now been discarded is the idea that the peptidase activity of the small intestine is deficient, however this normalizes with a gluten-free diet. Also gliadin carbohydrate side chains or gluten lectinlike properties (cytotoxic against epithelial cells) do not seem to be important. Finally, the intestinal mucosa permeability defect does not appear to be a major cause as it, as well, resolves with a gluten-free diet. Below are listed the major theories that seem to contribute to the development of celiac sprue.10

Environmental factors

It is now known that the cereal grains of wheat, rye, barley and oats (small amounts may be tolerated in some) disturb the small intestinal mucosa in celiac sprue patients. The further removed grains of rice, corn, sorghum, and millet are well tolerated. Prolamins (gliadins, secalins, and hordeins) are the alcohol-soluble proteins of gluten in these grains that are toxic to the small intestine (Figure 110). Originally it was thought that only one fraction of the prolamins was toxic, but now it appears that many fractions cause the typical mucosal changes. There also appears to be other environmental factors playing a role as monozygotic twins susceptible to the disorder do not always manifest the classical changes. It was discovered that a certain fraction of gluten (A-gliadin) had a 12 amino acid segment similar to the E1b protein of human adenovirus serotype 12.10 Kagnoff showed that 89% of untreated celiac sprue patients versus 17% of control subjects had evidence of prior infection with the virus. Two other similar viruses were also studied, however these demonstrated no correlation with celiac sprue. It was then proposed that this adenovirus via molecular mimicry may be the catalyst necessary for developing the disease in some who are already predisposed.11

Genetic Factors

It is felt that celiac sprue patients have a genetic predisposition. Studies have confirmed that the prevalence among first-degree relatives is as high as 10%. HLA identical siblings have a concordance rate of approximately 28-40% and monozygotic twins have a concordance rate of 70-75%.18 The fact that this study did not show all identical twins to be concordant supports the hypothesis that environmental factors other than gluten ingestion are influencing disease expression. Of note, not all sets of twins in the study that demonstrated a 75% concordance were proven to be identical.10

Celiac sprue is also associated with several HLA halotypes. It has been demonstrated that as many as 90% of affected individuals have HLA-B8, HLA-DR3 or HLA-DQw2 halotypes. When sampling the general population, 25-30% of individuals also possess this halotype and are disease free. Therefore it is estimated that only 0.1% of persons with the HLA susceptible halotypes eventually develop the disorder thus making genetic typing a poor screening test. In addition, the fact that concordance rates between HLA identical siblings and monozygotic twins are not analogous supports the claim that genes other than the HLA loci may be necessary for expression of the disease.9

Immunologic Factors

There are several humoral and cell-mediated mechanisms that may be responsible for the pathological changes seen in celiac sprue patients. These include antigliadin antibody triggering the complement cascade or invoking cytotoxic cell-mediated actions causing mucosal damage. These antibodies are also found in normal individuals so their role still has not been proven. Intraepithelial lymphocytes seen in the lamina propria of absorptive cells are known to increase greatly in affected patients. There is debate currently whether or not lymphokines produced by these cells are involved in mucosal injury.10

 

Pathology

Celiac sprue primarily affects the mucosa of the small intestine in a proximal to distal manner with changes beginning in the duodenum. The ileum is usually spared as the damaging glutens are often digested or absorbed prior to contacting this mucosa. The pathological changes are continuous with the length of small intestine involved correlating with the severity of the symptoms. The classical changes that occur include villous atrophy and crypt hyperplasia thus decreasing the villous:crypt ratio (causing flattening of the absorptive surface). However, the thickness of the mucosa remains fairly constant (Figure 22). The individual cells are noted to change from their typical columnar shape to a more cuboidal or squamous shape. Microvilli on the surface of the cells are also noted to decrease. The tight junctions between cells are also disturbed making them more permeable. Within the individual cells, mitotic activity is increased possibly contributing to the fact that these patients are at greater risk for lymphoma and other carcinomas. Intraepithelial lymphocytes, plasma cells, mast cells, and eosinophils are also increased in number.10

The entire realm of pathological changes need not be present for a patient to be diagnosed with celiac sprue. Research now is considering the changes seen to form a continuum between minimal changes seen in asymptomatic patients to severe changes seen in the worst cases. The mucosa injury can be seen just hours after ingestion of glutens. Resolution of the damage, however, takes weeks to months or may never occur. Finally, the pathological changes are not pathognomonic for celiac sprue and can be seen in other diseases. These include soy or milk protein allergy, tropical sprue, giardiasis, viral or eosinophilic gastroenteritis, malnutrition, intestinal bacterial overgrowth, common variable immunodeficiency, Zollinger-Ellison syndrome, and diffuse intestinal lymphoma.15

Clinical Features

Celiac sprue may present at almost any age, but most frequently it develops in early childhood or early adulthood. With the initiation of cereal grains into the diet, children usually between the ages of one and five first start to demonstrate the clinical manifestations. Most commonly these symptoms include failure to thrive; abdominal distention; anorexia; apathy or irritability; and soft, frequent, bulky, foul-smelling stools. Breast feeding may delay the onset of celiac sprue, however, the disease still occurs when glutens are introduced. Symptoms tend to remit during adolescence although the underlying disease may progress.14

Gastrointestinal Symptoms

The recurrence of celiac sprue in adulthood appears to peak in women in the third and fourth decades and slightly later in men. The most common presenting symptoms in adults include diarrhea, abdominal distention, flatulence, weakness, lassitude, and progressive weight loss.14 The diarrhea typically occurs three to four times a day (usually not exceeding ten) with most episodes occurring in the morning hours. The stools characteristically are bulky, loose, pale, floating secondary to the fat content, and foul-smelling.2 The diarrhea is thought to be a result of malabsorption of fats, carbohydrates, proteins, water and electrolytes. In addition, there may be a decrease in intraluminal digestion of nutrients secondary to fewer pancreatic secretions. The inability to reabsorb conjugated bile salts is also thought to contribute to the frequent stools. As a result of the severe diarrhea, most patients tend to demonstrate progressive weight loss. This symptom may be offset by some patients increasing their dietary intake and thus overcoming their malabsorption. Nonetheless, celiac sprue patients commonly exhibit abdominal distention and flatulence which more often occurs in the evenings. Abdominal pain is uncommon, and in advanced celiac sprue may be the first sign of an underlying cancer necessitating prompt evaluation.17

Extraintestinal Symptoms

In addition to the gastrointestinal symptoms of celiac sprue, patients may exhibit a vast array of other symptoms mainly due to malabsorption of vitamins and elements in the diet. Anemia has been estimated to occur in 40-90% of adults with advanced disease. Anemia, as the only presenting symptom, may even occur in up to 20% of patients. Studies have shown that approximately 75% of patients are iron deficient and as many as 95% are folate deficient. Both factors contribute to the patient’s anemia and consequently their weakness. Historically, it was believed that that the iron deficiency was due to poor absorption of iron and sloughing of epithelial cells containing iron.5 Research by Fine now has demonstrated that 57% of celiac sprue patients with diarrhea concurrently have heme-positive stools. The mechanism appears to involve both microerosions secondary to chronic inflammation, as well as weakness in the epithelial surface from sloughing, allowing red blood cells into the intestinal lumen.3 Vitamin B12 deficiency has also been a recognized contributor to anemia, however this is less likely as the distal ileum (where absorption occurs) is involved in only the most severe cases. Vitamin K deficiency, thrombocytosis, and hyposplenism have also been described in patients.

Osteopenia is also observed in the celiac sprue population. Factors that predispose a patient to this manifestation include decreased calcium absorption, decreased vitamin D absorption, and binding of calcium in the lumen of the intestine thus preventing further absorption. Nearly one third of affected individuals may experience bone pain, but fortunately few develop pathological fractures. Muscle cramps and tetany are also seen with low serum calcium levels. In the most severe forms, hypocalcemia may result in secondary hyperparathyroidism. In addition to these electrolyte abnormalities patients may concurrently have hypokalemia and hypomagnesemia.2

Neurological deficits are fairly common in celiac sprue patients. Paresthesias, sensory deficits, ataxia, and peripheral neuropathy are well described. Hypokalemia and vitamin B12 deficiency may be causative factors. Less frequently occurring but important neurological symptoms include spinal cord demyelination and cerebellar atrophy. Night blindness has also been observed secondary to vitamin A deficiency. Depression and anxiety have been diagnosed in others.17

The reproductive system is also susceptible to abnormalities in association with celiac sprue. Women may experience amenorrhea, delayed menarche, and infertility while men are prone to developing impotence and infertility. Pregnancy may even cause an exacerbation in symptoms.8

Physical Findings

The extent of the physical findings varies among celiac sprue patients usually correlating with the severity of small intestine involvement. Some patients may have no physical findings while others have numerous abnormalities on physical exam. General exam may reveal pallor secondary to anemia. Malabsorption tends to produce the characteristic weight loss, wasting, loose skin folds and even hypotension if the disease is advanced. Head and neck exam may exhibit cheilosis, glossitis, aphthous ulcers or dental enamel hypoplasia secondary to vitamin deficiencies. The tongue may be become red, sore, ulcerated and in extreme cases restrict swallowing ability. The abdominal exam in these patients is described as doughy, protuberant, or tympanic consistent with distended bowel loops filled with fluid and gas. Ascites occurs if hypoproteinemia becomes critical. Peripheral edema is also a manifestation of hypoproteinemia. The dermatologic exam may be significant for ecchymoses secondary to vitamin K deficiency, or hyperkeratosis follicularis secondary to vitamin A deficiency. Finally, neurological abnormalities include decreased deep tendon reflexes and decreased sensation as a consequence of peripheral neuropathy. Hypocalcemia may be demonstrated with a positive Chvostek or Trousseau sign. Lymphadenopathy is uncommon with typical celiac sprue, but if present should precipitate a work-up for lymphoma, a well-recognized complication.2

 

Diagnostic Studies

Malabsorption Studies

Malabsorption studies were the mainstay for diagnosing celiac sprue prior to being replaced by small bowel biopsies and serological tests. Malabsorption tests are very nonspecific and would not be helpful in the diagnosis of gastrointestinally asymptomatic patients. The D-xylose test, which requires a normal intestinal mucosa for absorption, has historically been used. Xylose, of which 60% is absorbed in the jejunum, would be abnormally low in both the serum and the urine after oral challenge. The sensitivity of this test approaches 95%, however, its specificity is quite low. The lactose intolerance test (with an inappropriately low glucose level after challenge), as well as the breath hydrogen test (with an inappropriately high hydrogen concentration in expired air) after lactose challenge both demonstrate malabsorption but again are nonspecific.15

Radiologic Studies

Upper gastrointestinal barium studies with small bowel follow through have little value in the initial diagnosis of celiac sprue as they as well are nonspecific. Barium studies do demonstrate dilation of small bowel loops in addition to coarsening and obliteration of the normal mucosal folds (Figure 32). These findings are most likely to be seen in the proximal small intestine, although with serious disease radiographic changes can be seen throughout the ileum. Barium studies may be of most use in aiding in the diagnosis of the complications of celiac disease. Irregularly narrowed segments of the small intestine may be consistent with lymphoma while rigidity may be consistent with collagenous sprue. Of note, plain films demonstrating osteopenia or pathological fractures can possibly be seen as part of the destruction of this multisystem disease.15

Serologic Studies

Various serological studies are now being developed and used to help in screening, diagnosing, and monitoring response to treatment of celiac sprue. None of these immunological markers have yet to replace small bowel biopsy as the diagnostic method of choice. Antigliadin (AGA), antireticulin (ARA), and antiendomysial (AEA) antibodies have all been studied to determine their usefulness. A summary of sensitivities, specificities, positive predictive values and negative predictive values appears below.15

 

 

Table 1

Celiac Sprue Antibodies15

Negative Predictive Value

       

IgG AGA

65% - 100%

50% - 60%

   

IgA AGA

52% - 99.9%

72.7% - 100%

   

IgG/IgA AGA

96% - 100%

96% - 97%

   

IgG ARA

50%

n/a

   

IgA ARA

97%

98%

   

IgA AEA

97%

98%

97%

98%

IgG/IgA AGA and IgA AEA

   

99.3%

99.6%

IgG antigliadin antibody is found in numerous autoimmune, dermatologic, infectious, and diarrhea syndromes as well as in normal children, thus demonstrating why it carries such a low specificity. IgA antigliadin antibody is a much better test however its use is limited as approximately 2% of celiac sprue patients are IgA deficient. IgG antireticulin antibody is also nonspecific as it is found in other inflammatory bowel disorders, but the similar IgA marker in adults appears to be very sensitive and specific. The most recently developed serologic test is IgA antiendomysial antibody, which has been shown to be present in only celiac sprue and dermatitis herpetiformis, a related skin disorder. The specificity of this serum test is very specific and very sensitive in adults, however in children less than 2 years of age, the sensitivity is much less (approximately 80%).15

In summary, one group of experts recommends that screening of high risk groups (i.e. first degree relatives) be conducted. Initial serum tests should include a hemoglobin, iron, folic acid, and IgG antigliadin antibody. If this antibody is positive, then an IgA antigliadin antibody should be obtained. Careful interpretation of this marker needs to be taken remembering the relatively high likelihood of selective IgA deficiency in this population. If this study is positive, the patient should undergo small intestinal biopsy.16 Current recommendations include treating asymptomatic patients with positive serological tests and the characteristic small bowel biopsy. Regression in the pathological changes has been demonstrated. It is uncertain at this time if asymptomatic patients with only a positive antibody test and normal small intestinal biopsy would benefit from treatment. These patients have been termed latent or silent celiac sprue. It has now been shown that a repeat biopsy after several months of a gluten-free diet is not necessary to document histological improvement. Rather, histological markers, such as IgA antiendomysium antibody, can be followed to show a trend back toward normal levels thus assuming pathological improvement. Conversely, after documenting a decline in a serologic marker with treatment, increasing antibody levels may suggest dietary noncompliance or progression of disease.15

Histopathologic Studies of the Small Intestine

The endoscopic proximal small intestinal biopsy is still the gold standard when making the diagnosis of celiac sprue. The standard area to biopsy is the distal duodenum near the ligament of Treitz. It is recommended that all patients undergo an intestinal biopsy to demonstrate the characteristic but not pathognomonic findings prior to embarking on a gluten-free diet. Classically, it was also recommended that celiac sprue patients then have a second biopsy after several weeks to months of treatment to document normalization of the mucosa. This practice may now be replaced by following serologic markers and clinical symptoms. In addition, some experts previously suggested a post-treatment third biopsy reconfirming the abnormal histology after reintroducing glutens into the diet. Gluten challenge is rarely conducted currently unless patients on a gluten-free diet never received a small bowel biopsy demonstrating the typical pathology. During the upper endoscopy procedure, flattening of the normal duodenal folds may also be observed.15

 

Associated Diseases

Dermatitis Herpetiformis

Dermatitis herpetiformis is a skin disorder that is found in as many as 5% of celiac sprue patients. Although only a small minority of celiac sprue patients have dermatitis herpetiformis, approximately 20% of those primarily diagnosed with the skin disorder have clinically symptomatic celiac sprue and nearly the remaining 80% have histological changes on small bowel biopsy. It is of no surprise that dermatitis herpetiformis is also associated with HLA-B8 and HLA-Dw3 major histocompatability complexes. The characteristic lesions manifest as vesicles, papulovesicles, or excoriations that are intensely pruritic or burning. The lesions typically form symmetrical groups of eruptions located on the scalp, elbows, extensor forearms, scapula, buttocks and knees (Figure 44). Biopsy reveals IgA deposits at the dermal/epidermal junction in either a granular or linear pattern. It is still uncertain whether dietary glutens or tissue antigens are responsible for the IgA deposition. Regression of these lesions occurs slowly with a gluten-free diet. However, many patients with the skin disorder need prompt treatment as the lesions are extremely irritating. Dapsone may be used for immediate relief but the typical diet must be instituted as well.6

Other Disorders

IgA deficiency occurs ten times more frequently in celiac sprue patients than in the general population. Again it must be reinforced that IgA serological markers will be negative in this population. Several endocrine disorders exhibit an association. Of a group of insulin dependent diabetes mellitus patients, 4.1% had asymptomatic celiac sprue. Similarly, 4.8% of patients with autoimmune thyroid disease had celiac sprue. These cases were determined to have celiac sprue if their antireticulin antibody was positive and not by small bowel biopsy. Associated rheumatological disorders include Sjogren’s syndrome found in 3.3% of celiac sprue affected individuals, as well as more rare cases of systemic lupus erythematosis, mixed cryoglobulinemia, vasculitis, and rheumatoid arthritis. Weaker associations have been described with the renal disease of IgA mesangial nephropathy, the hepatic diseases of primary biliary cirrhosis and primary sclerosing cholangitis, and the gastrointestinal disorder of inflammatory bowel disease.1 These relationships may be helpful when attempting to make the diagnosis of celiac sprue as a patient may present with several vague, unrelated symptoms.

 

Treatment and Prognosis

The therapy of choice for celiac sprue patients is lifelong adherence to a gluten-free diet. Avoidance of all products that contain wheat, rye, barley and oats is necessary initially. With these dietary modifications patients may have an improvement in their symptoms in as soon as 48 hours, although the majority have slower improvement over a few weeks. Approximately half of the cases will demonstrate resolution or marked improvement of histological lesions within several months, but the remainder show little to no improvement. The strict diet may be very difficult to follow as numerous foods have gluten present in them. For example, common foods such as ice cream, coffee, soup, salad dressing, lunch meat, mustard, ketchup, tomato sauce, and peanut butter may need to be eliminated. There are now many gluten-free products available (i.e. pastas and breads), however taste is usually compromised. Once a patient has shown improvement clinically, in addition to either histological resolution or decline in antibody titers, a trial with oats may be attempted. Some physicians also allow their patients to try other cereal grains as small amounts may be tolerated. In others, reintroducing glutens produces large, watery stools with hours of ingestion.16

The most common reason for treatment failure is dietary noncompliance. Intensive dietary education is essential. Hospitalization may even be necessary to ensure that the patient is receiving a gluten-free diet. Those individuals who do not improve are termed refractory sprue and may require corticosteroids. Many do respond to this second line therapy. However, a minority of patients still have progressive symptoms and agents such as cyclosporine and azathioprine have been used. Benefits of these drugs have not yet been determined (Figure 517).16

Many celiac sprue patients also have lactase deficiency secondary to mucosal damage. Therefore, milk products should be avoided initially, but may be reintroduced when symptoms are under control. Anemic patients should have iron, folic acid, and vitamin B12 supplemented as necessary. Vitamin K should be replaced if bleeding is prominent. Calcium, magnesium, and vitamin D warrant supplementation if tetany or osteopenia is present. Finally, in general, all patients with celiac sprue should be placed on a multivitamin to circumvent other vitamin, mineral, and trace element deficiencies.17

The prognosis for celiac sprue is excellent if the disease is recognized by the physician and the patient is able to adhere to a gluten-free diet. However, when not diagnosed the disease could prove to be fatal. Only a small fraction of diagnosed patients who are undergoing treatment develop complications and do poorly.8

 

Complications

Malignancy

Celiac sprue patients are at a twofold increased risk of developing a malignancy with approximately 50% of these being lymphoma, typically T-cell. The remainder of the malignancies are mainly comprised of carcinomas of the esophagus (most common), mouth, pharynx, larynx, and small intestine. However, the relative risk of lymphoma is 25 to 120 times that of the general population. This complication is more common in men, older individuals, and those having untreated celiac sprue for over ten years. One should be alerted when a previously well-controlled patient on a gluten-free diet develops progressive weight loss, abdominal pain, intestinal bleeding, muscle weakness, pyrexia, lymphadenopathy, or malabsorption. Lymphoma may precede the diagnosis of celiac sprue as well. In a study by Swinson, 66.4% of cases had lymphoma diagnosed after their celiac sprue had manifested itself, 18.7% developed both diseases concurrently, and 14.9% had lymphoma present prior to celiac sprue. The time between diagnosis of celiac sprue and development of intestinal lymphoma averaged eight years. The prognosis is grim as the average life expectancy after diagnosis is only nine months, and the five-year survival rate is 9.5%. Surgical resection of the diseased bowel, radiation therapy, and chemotherapy have all been attempted with minimal benefit.12

Researchers currently can only speculate as to why celiac sprue predisposes patients to developing lymphoma. One leading hypothesis includes an increased occurrence of mutations in the small intestine secondary to the increased mitotic activity. Increased permeability of the mucosa allowing greater contact with carcinogens has also been proposed. There is also the belief that oncoviruses may have greater success attacking the vulnerable mucosa.13

Holmes demonstrated that a gluten-free diet is protective against cancer morbidity. He and his colleagues followed a group of 210 celiac sprue patients for the development of intestinal lymphoma as well as carcinomas of the mouth, pharynx, and esophagus. A time span of ten years was used. Those patients that adhered to a strict gluten-free diet had only a 1.2 times increased risk of developing one of these cancers, those who ate a reduced gluten diet had a 5.0 relative risk, and those who consumed a regular diet had a 10.7 relative risk. Thus he concluded that a strict gluten-free diet reduces the risk of developing a malignancy to that of the general population.7

Ulcerative Jejunoileitis

This rare complication is characterized by chronic benign ulcers occurring most frequently in the jejunum but also in the ileum and colon. The older celiac sprue patient is most likely affected. Careful evaluation should be undertaken when a previously diet-controlled patient redevelops the symptoms with which they initially presented. This condition may also be complicated by intestinal strictures causing obstruction. Other ominous conditions may include intestinal bleeding or peritonitis signifying perforation. These patients tend to have a poor prognosis (75% mortality) unless the involved segment of intestine can be promptly resected.2

Collagenous Sprue

This disorder is diagnosed by histological exam of the small intestinal biopsy finding collagen deposition in the subepithelial layer of the mucosa. It appears that this complication differs from celiac sprue by the amount of collagen deposited, for as many as 36% of standard celiac sprue patients have some collagen present on biopsy. Barium studies of these patients demonstrate rigidity of the small intestinal loops (Figure 617). Collagenous sprue patients tend to be refractory to a gluten-free diet, however a small portion do respond to corticosteroids.2

Neurological and Psychiatric Complications

This group of complications may develop regardless of the celiac sprue patient’s dietary compliance. Neurological complaints predominantly affect the lower extremities more than the upper extremities with sensory ataxia being the most common presentation. Symptoms include numbness, tingling, pain, weakness, and an unsteady gait. Physical exam may reveal incoordination, decreased strength, or decreased sensation usually in a glove and stocking distribution. Depression also tends to occur more frequently in this population. Causative factors may be the chronic, unrelenting symptoms that newly presenting patients have grown to accept. Although dietary limitations may at first seem to be a burden, patients usually exhibit an improved mood with resolution of symptoms on a gluten-free diet.2

 

Summary

Celiac sprue is a small intestinal malabsorption disorder that may first manifest itself in children, then reappear in early adulthood. Patients demonstrate an intolerance for the gliadin fraction of gluten found in wheat, rye, barley, and oats. Commonly presenting symptoms of this disorder include abdominal discomfort, diarrhea, and progressive weight loss; although numerous cases have been reported where the patients have only vague extraintestinal findings. Small bowel biopsy showing some degree of villous atrophy and crypt hyperplasia is required to confirm the diagnosis. Serological testing, however, is playing a greater role in screening and in following a patient’s response to therapy. Treatment consists of a gluten-free diet which is difficult to adhere to as many common foods have gluten in them. A clinical response to this diet is a salient feature in this disease. The prognosis is usually good with a few patients becoming refractory to treatment then possibly benefiting from corticosteroids. The increased risk of lymphoma and other malignancies has been shown to decrease with the elimination of gluten from the diet. In summary, the clinician must always consider celiac sprue in the differential diagnosis as it is a potentially curable disorder when treated properly, and a potentially fatal disorder when overlooked.